Artivion (AORT) vs iRadimed (IRMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
iRadimed (IRMD) has outperformed Artivion (AORT) over the past year, gaining 14.9% versus a loss of 46.7%. Over five years, IRMD leads with a +133.1% price change compared with +1.2% for AORT. iRadimed is the larger company by market cap ($1.09 billion vs $1.05 billion), about 1.0 times the size.
On valuation, Artivion trades at a lower forward P/E (28.9x vs 34.8x for iRadimed). iRadimed pays a dividend yielding 0.90%, while Artivion does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AORT | IRMD |
|---|---|---|
| Share price | $21.61 | $85.47 |
| Market cap | $1.05B | $1.09B |
| 1-day change | -1.05% | +0.77% |
| YTD return | -52.62% | -12.14% |
| 1-year return | -46.66% | +14.93% |
| 5-year return | +1.17% | +133.08% |
| P/E ratio (TTM) | — | 47.48 |
| Forward P/E | 28.88 | 34.84 |
| EPS (TTM) | $-0.07 | $1.80 |
| Dividend yield | 0.00% | 0.90% |
| Annual dividend | $0.00 | $0.77 |
| 52-week high | $48.25 | $107.90 |
| 52-week low | $19.16 | $71.34 |
| Distance from 52-week high | -55.21% | -20.79% |
| Analyst consensus | none | none |
| Avg. price target upside | +95.05% | +38.06% |
| Average volume | 639.01K | 124.88K |
| Shares outstanding | 48.76M | 12.79M |
| Employees | 1,800 | 166 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IRMD has outperformed AORT by 61.6 percentage points over the past year.
About Artivion
AORT stock →Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide.
Healthcare · Medical Devices · 1,800 employees
About iRadimed
IRMD stock →IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device.
Healthcare · Medical Devices · 166 employees
AORT vs IRMD FAQ
Which is bigger, Artivion or iRadimed?
iRadimed (IRMD) is larger, with a market capitalization of $1.09B compared with $1.05B for Artivion (AORT).
Which stock has performed better over the past year, AORT or IRMD?
IRMD returned +14.93% over the past 12 months, compared with -46.66% for AORT (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Artivion or iRadimed?
iRadimed pays a dividend yielding 0.90%, while Artivion does not currently pay a regular dividend.
Are Artivion and iRadimed in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.